InspireMD (NSPR) Cost of Revenue (2016 - 2025)
InspireMD filings provide 16 years of Cost of Revenue readings, the most recent being $5.2 million for Q4 2025.
- On a quarterly basis, Cost of Revenue rose 173.58% to $5.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.3 million, a 103.82% increase, with the full-year FY2025 number at $16.6 million, up 172.75% from a year prior.
- Cost of Revenue hit $5.2 million in Q4 2025 for InspireMD, up from $4.4 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $5.2 million in Q4 2025 to a low of $438000.0 in Q4 2022.
- Median Cost of Revenue over the past 5 years was $1.1 million (2023), compared with a mean of $1.5 million.
- Biggest five-year swings in Cost of Revenue: soared 336.14% in 2021 and later crashed 59.67% in 2022.
- InspireMD's Cost of Revenue stood at $1.1 million in 2021, then crashed by 59.67% to $438000.0 in 2022, then skyrocketed by 320.55% to $1.8 million in 2023, then increased by 3.96% to $1.9 million in 2024, then soared by 173.58% to $5.2 million in 2025.
- The last three reported values for Cost of Revenue were $5.2 million (Q4 2025), $4.4 million (Q3 2025), and $1.5 million (Q2 2025) per Business Quant data.